-
admin
Posts
TRxADE Health, Inc. Files its Q1 10-Q; Reporting Positive Net Income Due to Asset Sale
TAMPA, FL, June 27, 2024 (GLOBE NEWSWIRE) — TRxADE HEALTH Inc. (Nasdaq: MEDS) (the “Company”), announced today that with the filing of its Quarterly Report...
Cheche Group Announces Strategic Partnership with BAIC Group’s Insurance Provider
BEIJING, June 27, 2024 /PRNewswire/ — Cheche Group Inc. (NASDAQ: CCG) (“Cheche” or the “Company”), China’s leading auto insurance technology platform, today announced that it...
Crown Laboratories, Inc. and BIOJUVE® Celebrate World Microbiome Day 2024
Embracing the Power of the Skin Microbiome with BIOJUVE JOHNSON CITY, Tenn., June 27, 2024 /PRNewswire/ — Microbiome research has revolutionized our understanding of human...
MSME Day 2024: Alibaba.com Commits to Scaling AI Tools for MSMEs
Strategic plans for a diverse supplier network and enhanced trade opportunities unveiled GENEVA, June 27, 2024 /PRNewswire/ — Alibaba.com, a leading platform for global business-to-business...
Recurrent Energy Closes $103 Million Tax Credit Transfer Agreement with Bank of America for North Fork Solar Project
The 160 MW North Fork Solar Project is now in operation, supplying power to the Oklahoma Municipal Power Authority GUELPH, ON, June 27, 2024 /PRNewswire/...
Odaseva Raises $54M Series C Round to Expand Product Offerings and Continue Category Leadership
Latest funding round capitalizes on recent growth, catalyzing further product innovation and expansion into new markets SAN FRANCISCO, June 27, 2024 /PRNewswire/ — Odaseva, the...
Vancouver, Canada’s Highly Anticipated Cultural Destination, Oakridge Park, Announces the “Oakridge Summer Social,” its Special Summer Series for the Community
The Inaugural Oakridge Summer Social Celebrates Canada Day with the Announcement of Latest Canadian Retailers Set to Open at the World-Class Destination in Spring 2025...
Elevai Labs Inc. Subsidiary, Elevai Skincare to Debut Upcoming New Product Line at The Aesthetic Show 2024
NEWPORT BEACH, Calif., June 26, 2024 (GLOBE NEWSWIRE) — ELEVAI LABS, INC., (NASDAQ: ELAB) a pioneering force in medical aesthetics, is excited to announce Elevai...
Nxera Pharma Receives US$10 Million from AbbVie as Collaboration Targeting Neurological Diseases Achieves First R&D Milestone
Tokyo, Japan and Cambridge, UK, 27 June 2024 – Nxera Pharma Co. Ltd (“Nxera”; TSE 4565), announces that it has reached an important R&D milestone...
EPKINLY® (epcoritamab-bysp) Approved by U.S. FDA for Patients with Relapsed or Refractory (R/R) Follicular Lymphoma (FL)
Company Announcement Approval based on results from Phase 1/2 EPCORE® NHL-1 study, which demonstrated durable, clinically meaningful treatment responses in patients with challenging-to-treat R/R FL...